Identification of a novel de novo mutation of SETBP1 and new findings of SETBP1 in tumorgenesis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Identification of a novel de novo mutation of SETBP1 and new findings of SETBP1 in tumorgenesis ; volume:18 ; number:1 ; day:7 ; month:5 ; year:2023 ; pages:1-16 ; date:12.2023
Orphanet journal of rare diseases ; 18, Heft 1 (7.5.2023), 1-16, 12.2023
- Urheber
-
Wang, Hongdan
Gao, Yue
Qin, Litao
Zhang, Mengting
Shi, Weili
Feng, Zhanqi
Guo, Liangjie
Zhu, Bofeng
Liao, Shixiu
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13023-023-02705-6
- URN
-
urn:nbn:de:101:1-2023090613140137619607
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wang, Hongdan
- Gao, Yue
- Qin, Litao
- Zhang, Mengting
- Shi, Weili
- Feng, Zhanqi
- Guo, Liangjie
- Zhu, Bofeng
- Liao, Shixiu
- SpringerLink (Online service)
Ähnliche Objekte (12)
Heterogeneous Firms in a Product Fragmentation World
Computer‐Free Autonomous Navigation and Power Generation Using Electro‐Chemotaxis
UAV image and intelligent detection of building surface cracks
Low-cost client-side encryption and secure Internet of things (IoT) provisioning
Identifying the antecedents for the green transformation of resource-exhausted cities in China
Analysis of codon usage bias of WRKY transcription factors in Helianthus annuus
Decomposing China's Export Growth into Extensive Margin, Export Quality and Quantity Effects
Image De-occlusion via Event-enhanced Multi-modal Fusion Hybrid Network
Degradation modeling of degradable copolymers for biomimetic scaffolds
Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
Correction to: Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
Heterogeneous Firms in a Product Fragmentation World
Computer‐Free Autonomous Navigation and Power Generation Using Electro‐Chemotaxis
UAV image and intelligent detection of building surface cracks
Low-cost client-side encryption and secure Internet of things (IoT) provisioning
Identifying the antecedents for the green transformation of resource-exhausted cities in China
Analysis of codon usage bias of WRKY transcription factors in Helianthus annuus
Decomposing China's Export Growth into Extensive Margin, Export Quality and Quantity Effects
Image De-occlusion via Event-enhanced Multi-modal Fusion Hybrid Network
Degradation modeling of degradable copolymers for biomimetic scaffolds
Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
Correction to: Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
Heterogeneous Firms in a Product Fragmentation World
Computer‐Free Autonomous Navigation and Power Generation Using Electro‐Chemotaxis
UAV image and intelligent detection of building surface cracks
Low-cost client-side encryption and secure Internet of things (IoT) provisioning
Identifying the antecedents for the green transformation of resource-exhausted cities in China
Analysis of codon usage bias of WRKY transcription factors in Helianthus annuus
Decomposing China's Export Growth into Extensive Margin, Export Quality and Quantity Effects
Image De-occlusion via Event-enhanced Multi-modal Fusion Hybrid Network
Degradation modeling of degradable copolymers for biomimetic scaffolds
Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma